Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. [Phase 3]

View source ↗

Summary

Pfizer's RSVpreF Phase 3 trial evaluating efficacy and safety in infants born to women vaccinated during pregnancy has completed and posted results. The trial a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSVpreF

Snippet

Sponsor: Pfizer | Conditions: Respiratory Tract Infection | Phase 3 | Status: COMPLETED | Results posted: 2025-02-11